CLINICAL_TRIALS
trial_result
· 2022-10-12
Clinical Trial Update: Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine [Phase 4]
Summary
Phase 4 trial evaluating safety and immunogenicity of simultaneous administration of EV71 vaccine and influenza vaccine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: China National Biotec Group Company Limited | Conditions: Enterovirus Infections, Influenza | Phase 4 | Status: COMPLETED